Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas
Latest Information Update: 07 Nov 2023
At a glance
- Drugs Deoxycholic acid (Primary)
- Indications Neurofibroma; Neurofibromatosis 1
- Focus Adverse reactions
- 01 Nov 2023 Planned End Date changed from 1 Dec 2023 to 1 Dec 2024.
- 01 Nov 2023 Planned primary completion date changed from 1 Jun 2023 to 1 Dec 2024.
- 01 Nov 2023 Status changed from recruiting to active, no longer recruiting.